









Markets
/
Stocks
/
nasdaq-cvrx
/

CVRx Inc

CVRX

8.870USD

-0.410-4.42%

Close 03/30, 16:00（ET）Quotes delayed by 15 min

171.15MMarket Cap

LossP/E TTM



CVRx Inc

8.870

-0.410-4.42%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of CVRx Inc

Currency: USD Updated: 2026-03-27

Key Insights

CVRx Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 61 out of 208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 12.20.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

CVRx Inc's Score

Industry at a Glance

Industry Ranking

61 / 208

Overall Ranking

164 / 4542

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

CVRx Inc Highlights

StrengthsRisks

CVRx, Inc. is a commercial-stage medical device company. The Company is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The Company's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure with reduced ejection fraction (HFrEF) and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. Barostim is a minimally invasive neuromodulation device that consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead, and is programmed by a wireless clinician-controlled programmer that communicates with the IPG.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 44.17% year-on-year.

Growing

The company is in a growing phase, with the latest annual income totaling USD 56.65M.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 56.65M.

Fairly Valued

The company’s latest PE is -4.36, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 17.05M shares, decreasing 0.31% quarter-over-quarter.

Held by PRFDX

Star Investor PRFDX holds 1.65K shares of this stock.

Analyst Rating

Based on 7 analysts

Buy

Current Rating

12.200

Target Price

+31.47%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-03-27

The current financial score of CVRx Inc is 6.42, ranking 150 out of 208 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is low. Its latest quarterly revenue reached 16.02M, representing a year-over-year increase of 4.45%, while its net profit experienced a year-over-year increase of 12.05%.

Score

Industry at a Glance

Previous score

6.42

Change



Financials

7.59

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

7.19

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

4.21

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

5.98

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.11

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

CVRx Inc's Company Valuation

Currency: USD Updated: 2026-03-27

The current valuation score of CVRx Inc is 7.22, ranking 109 out of 208 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -4.36, which is -49.11% below the recent high of -2.22 and -268.06% above the recent low of -16.05.

Score

Industry at a Glance

Previous score

7.22

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 61/208

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-03-27

The current earnings forecast score of CVRx Inc is 7.71, ranking 120 out of 208 in the Healthcare Equipment & Supplies industry. The average price target is 12.00, with a high of 14.00 and a low of 7.00.

Score

Industry at a Glance

Previous score

7.71

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 7 analysts

Buy

Current Rating

12.200

Target Price

+36.92%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

115

Total

Median

Average

Company name

Ratings

Analysts

CVRx Inc

CVRX

Medtronic PLC

MDT

Stryker Corp

SYK

Zimmer Biomet Holdings Inc

ZBH

Abbott Laboratories

ABT

Dexcom Inc

DXCM

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-03-27

The current price momentum score of CVRx Inc is 8.58, ranking 14 out of 208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 10.13 and the support level at 7.39, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

8.83

Change

-0.25

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(3)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

0.142

Buy

RSI(14)

61.040

Neutral

STOCH(KDJ)(9,3,3)

70.108

Neutral

ATR(14)

0.638

High Vlolatility

CCI(14)

90.924

Neutral

Williams %R

33.942

Buy

TRIX(12,20)

0.998

Sell

StochRSI(14)

14.732

Sell

Moving Average

Sell(1)

Neutral(0)

Buy(5)

Indicators

Value

Direction

MA5

8.900

Sell

MA10

8.652

Buy

MA20

8.308

Buy

MA50

7.221

Buy

MA100

7.921

Buy

MA200

7.851

Buy

Institutional Confidence

Currency: USD Updated: 2026-03-27

The current institutional shareholding score of CVRx Inc is 7.00, ranking 81 out of 208 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 80.90%, representing a quarter-over-quarter decrease of 1.58%. The largest institutional shareholder is The Vanguard, holding a total of 1.12M shares, representing 4.26% of shares outstanding, with 10.31% increase in holdings.

Score

Industry at a Glance

Previous score

7.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Johnson & Johnson Innovation-JJDC, Inc.

4.04M

-1.50%

New Enterprise Associates (NEA)

2.03M

Vensana Capital Management LLC

1.71M

Gilde Equity Management Benelux B.V.

1.23M

-10.01%

The Vanguard Group, Inc.

Star Investors

1.09M

+1.20%

BlackRock Institutional Trust Company, N.A.

939.45K

-1.01%

Jain (Mudit Kumar)

938.43K

+0.18%

Balyasny Asset Management LP

696.26K

+3.20%

Silvercrest Asset Management Group LLC

359.38K

-2.83%

Risk Assessment

Currency: USD Updated: 2026-03-27

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of CVRx Inc is 4.08, ranking 112 out of 208 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.20. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.